Stay updated with breaking news from Dr Albert Bourla. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Merck today announced it has strengthened its Oncology franchise by regaining exclusive worldwide rights to develop, manufacture, and commercialize anti-programmed death ligand-1 (PD-L1) antibody BAVENCIO® (avelumab) following the termination of their Alliance agreement with Pfizer.
US Trade Rep Katherine Tai discusses increasing vaccine production with Pfizer ANI | Updated: Apr 27, 2021 11:11 IST Washington [US], April 27 (ANI): United States Trade Representative Katherine Tai on Monday (local time) met virtually with Dr Albert Bourla, Chairman and Chief Executive Officer of Pfizer, to discuss increasing vaccine production and global health issues. Both sides also discussed the proposed waiver to certain provisions of the World Trade Organization's (WTO) Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) for ...
Pfizer CEO says there is 'encouraging' data on whether its vaccine stops Covid transmission “We know that in animals, [there is] significant protection from transferring the virus,” Dr Albert Bourla told an the EPP Group health event. By Gráinne Ní Aodha Wednesday 13 Jan 2021, 3:12 PM Jan 13th 2021, 3:12 PM 55,153 Views 40 Comments THE CEO OF Pfizer has said that there is “encouraging” data on whether the Pfizer BioNTech vaccine st...